Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Docusate Sodium has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Psyllium works by holding water in the stool mass through gel formation, while docusate works as a surfactant lowering surface tension so water and lipid mix into the stool. Two different physical routes to the same softening endpoint, which is why they get combined. Both depend entirely on adequate fluid intake to do anything. The 2025 paper is a narrative review, so it summarises rather than tests the combination.
As a surfactant, docusate lowers interfacial tension and can increase the apparent solubility of fat-soluble compounds sharing the gut lumen with it. Direction of the net effect depends on transit time, since faster transit reduces contact time even as solubilisation improves. Fat-soluble vitamins are the class where this matters. The interaction is mechanistic and dose-dependent rather than a measured outcome.
Retinol and the carotenoids are absorbed through micellar packaging, which a surfactant alters. Whether more or less is absorbed depends on how much transit time is shortened at the same time. Long-term regular use of any softening or stimulant laxative is the situation where fat-soluble vitamin status is worth watching. Occasional use is a different picture.
Mineral oil is intended to stay in the lumen and is not meant to be absorbed. Docusate as a surfactant increases its systemic uptake, which is the specific reason the combination is discouraged in standard references. This is one of the better-characterised docusate interactions. Read it as a caution, not a pairing.
Osmotic agents pull water into the lumen; docusate helps that water incorporate into the stool mass rather than passing alongside it. The mechanisms are complementary rather than redundant. Combining them raises the total effect and the potential for fluid and electrolyte shift. Anyone using both regularly should be watching hydration.
Colonic secretion of potassium rises with stool output, so sustained laxative use is a route of potassium loss. This is a well-described consequence of chronic laxative use of any class. It is a reason to limit duration rather than a reason to add potassium alongside. Occasional use does not raise the same concern.
Pancreatic lipase acts at the oil and water interface, and its activity depends on how that interface is organised. An anionic surfactant changes interfacial properties, which can shift lipolysis in either direction depending on concentration. A 2020 sheep study reported changes in ruminal digestive enzyme activity with docusate, though ruminant digestion is a poor model for the human gut. Read the mechanism as plausible and the animal data as separate.
Nothing specific on file for Docusate Sodium. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 2 we read for Docusate Sodium. The full linked list is below.
7 sources behind our Docusate Sodium verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 165,407 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Docusate Sodium is, not how risky it is. A report is not proof Docusate Sodium caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.